I chose an article from The New York Times that was written by
Nicholas Bakalar. This article followed a study about the possibility
of low doses of aspirin lower the risk of pancreatic cancer. This article
stated that the National Cancer
Institute estimates there will be about 46,000 diagnoses
of Pancreatic cancer with a 93 percent mortality rate every year and more than
40,000 deaths,
This study was published online in Cancer
Epidemiology, Biomarkers & Prevention, after a five year study. The researchers matched aspirin use in 362
pancreatic cancer patients with 690 arbitrarily selected controls. The participants
were asked about past and present regular use of aspirin, defined as at least
once a week for three months.
The potential impact of unrestricted web publishing through mass
media as related to pancreatic cancer could be devastating. This is a
sensitive subject and if used incorrectly it could cause some major health
issues.
The use of aspirin has been linked to several side effects such
as: liver failure, kidney failure, ulcers, loss of hearing and
hemorrhagic stroke. So it is pertinent that the use of aspirin is
done conducted under a doctor’s supervision.
cebp.aacrjournals.org
Surveillance
Epidemiology and End Results Program
No comments:
Post a Comment